James M Rae Selected Research

Drug Therapy (Chemotherapy)

1/2023	Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial.
1/2020	Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
1/2016	The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer.
3/2012	CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.
10/2009	Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897.
8/2009	Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
2/2009	Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?
3/2007	Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James M Rae Research Topics

Disease

83	Breast Neoplasms (Breast Cancer) 04/2024 - 12/2003
49	Neoplasms (Cancer) 02/2024 - 08/2003
5	Circulating Neoplastic Cells 01/2021 - 07/2008
5	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2004
5	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 02/2005
4	Hot Flashes 10/2009 - 12/2003
3	Melanoma (Melanoma, Malignant) 12/2021 - 01/2004
2	Pain (Aches) 10/2022 - 02/2012
2	Triple Negative Breast Neoplasms 01/2022 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 01/2020
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Bone Diseases (Bone Disease) 01/2022
1	Retinoblastoma (Glioblastoma, Retinal) 01/2022
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2019
1	Disease Progression 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2016
1	Cardiotoxicity 02/2016
1	Syndrome (Syndromes) 01/2016

Drug/Important Bio-Agent (IBA)

29	Hormones (Hormone)IBA 02/2024 - 02/2005
23	Estrogen ReceptorsIBA 01/2023 - 01/2008
22	Estrogens (Estrogen)FDA Link 03/2022 - 07/2005
20	Tamoxifen FDA LinkGeneric 03/2022 - 12/2003
18	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2017 - 12/2003
16	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2004
15	Aromatase InhibitorsIBA 04/2024 - 05/2009
14	Letrozole (Femara)FDA LinkGeneric 10/2022 - 03/2012
11	exemestane (Aromasin)FDA Link 10/2022 - 04/2013
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2005
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
7	Estrogen Receptor alphaIBA 01/2019 - 07/2005
7	ParaffinIBA 01/2016 - 08/2003
6	Fulvestrant (Faslodex)FDA Link 03/2022 - 01/2016
6	EnzymesIBA 11/2010 - 08/2003
5	AndrogensIBA 01/2022 - 06/2006
4	Estradiol (Delestrogen)FDA LinkGeneric 03/2022 - 01/2008
4	Anastrozole (Arimidex)FDA LinkGeneric 10/2017 - 03/2012
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2016 - 01/2006
4	4-hydroxy-N-desmethyltamoxifenIBA 01/2016 - 12/2005
4	Formaldehyde (Formol)FDA Link 01/2016 - 09/2004
4	Messenger RNA (mRNA)IBA 11/2014 - 01/2006
3	Cytochrome P-450 CYP3AIBA 01/2019 - 01/2005
3	SteroidsIBA 01/2019 - 05/2009
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 11/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 03/2007
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2020
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2021
2	LigandsIBA 04/2020 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2020
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2019 - 04/2006
2	Small Interfering RNA (siRNA)IBA 02/2017 - 03/2007
2	Phosphotransferases (Kinase)IBA 02/2017 - 04/2006
2	Estrone FDA Link 01/2017 - 02/2012
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017 - 12/2005
2	estrone sulfate (Evex)FDA Link 01/2017 - 02/2012
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2005 - 12/2003
1	taxaneIBA 10/2022
1	AZD9496IBA 03/2022
1	Pamidronate (Aredia)FDA LinkGeneric 01/2022
1	Retinoblastoma ProteinIBA 01/2022
1	A-1331852IBA 01/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	navitoclaxIBA 01/2022
1	thymidine kinase 1IBA 11/2021
1	PhycoerythrinIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Cyclin-Dependent Kinase 4IBA 12/2020
1	palbociclibIBA 12/2020
1	seviteronelIBA 01/2020
1	LyasesIBA 01/2020
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 01/2020
1	Androgen Receptor AntagonistsIBA 01/2020
1	pazopanib FDA Link 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Cytochrome P-450 CYP3A InhibitorsIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	4-hydroxybenzoic acid (p-hydroxybenzoate)IBA 01/2018
1	butylparabenIBA 01/2018
1	Cyclin CIBA 02/2017
1	IceIBA 12/2016
1	Edetic Acid (EDTA)FDA Link 12/2016
1	LipidsIBA 03/2016
1	AnthracyclinesIBA 02/2016
1	Progesterone FDA LinkGeneric 01/2016
1	Long Noncoding RNAIBA 01/2016
1	abirateroneIBA 01/2016
1	Vitamin E FDA LinkGeneric 01/2016
1	SeleniumIBA 01/2016

Therapy/Procedure

40	Therapeutics 02/2024 - 08/2003
8	Drug Therapy (Chemotherapy) 01/2023 - 03/2007
4	Radiotherapy 01/2022 - 02/2005
3	Adjuvant Chemotherapy 01/2019 - 10/2009
1	Oral Administration 01/2023
1	Time-to-Treatment 10/2022
1	Precision Medicine 01/2018
1	Castration 01/2016